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Dendritic nanocarriers based on
hyperbranched polymers
Indah Nurita Kurniasih, Juliane Keilitz and Rainer Haag*
Hyperbranched polymers are obtained through one-step polymerization reactions and exhibit properties
that are very similar to those of perfect dendrimer analogues. Therefore, hyperbranched polymers are a
suitable alternative for perfect dendrimers as building blocks for dendritic nanocarrier systems. With
regard to using soluble hyperbranched polymers as carrier systems, their flexible chains are a major
benefit as they can adopt and compartment guest molecules. Upon encapsulation, the properties of the
host decides the fate of the guest, e.g., solubility, but the host can also shield a guest from the
environment and protect it, e.g., from degradation and deactivation. With regard to the advantages of
using hyperbranched polymers as nanocarrier systems and their scalable synthesis, we will discuss
diﬀerent types of hyperbranched polymers and their application as nanocarrier systems for drugs, dyes,
and other guest molecules.
Introduction
Nanocarriers are nanoparticulate materials that are able to
bind and/or encapsulate nanosized objects to protect, trans-
port, and ideally release them at a given time or location. Their
size ranges from 1–100 nm and they have been constructed
from a wide range of materials, including organic (e.g., polymers)
as well as inorganic materials (e.g., metal, metal oxide, and
nonmetal oxide). Further functionalisation can be used to control
and adjust the nanocarrier properties.
There is a vast variety of guest molecules that have been
transported with nanocarrier systems, including drugs, dyes,
imaging agents, catalysts, metal nanoparticles, and enzymes;
however, most research done in the field is focussed on medical
applications, i.e., drug treatment as well as diagnostic purposes.1,2
Other fields are the stabilization of catalysts, e.g., metal nano-
particles and enzymes.
The major and most important advantages of nanocarriers
that apply to all fields of application, is their size in the
nanometre range as well as their large surface-to-volume ratio,
which favour the adsorption and/or incorporation of payloads.
The nanoparticles’ size is also helpful with regard to the
separation of any nanocarrier system (with and without cargo)
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from small molecules. A number of easy separation techniques
are available, e.g., (membrane) filtration, precipitation, and gel
permeation chromatography. All of these make use of the diﬀer-
ence in size of small molecules versus nanoparticulate objects.3
With regard to using soluble macromolecules as carrier
systems, their flexible chains are a major benefit as they can
adopt and compartiment guest molecules. Upon encapsulation,
the properties of the host decide about the fate of the guest. The
host can shield a guest from the environment and protect it,
e.g., from degradation and deactivation. For instance, with the
help of an appropriate nanocarrier, hydrophobic drugs can be
solubilised and transported in water. The carrier might even be
able to transport the drug to a certain site in the body, where it
is finally released and can act its cure. Upon encapsulation, it is
not only the drug that is protected from its environment, but
also the system to which the drug is applied. Usually, the
encapsulation of drugs and, ideally, their targeted release, leads
to a reduced systemic toxicity of the drugs, which is a conse-
quence of the shielding, but also caused by the fact that smaller
amounts of drug have to be applied to achieve the same eﬀect.
Additionally, the high density of functional groups allows to
tune the size, solubility, and biocompatibility as well as to
attach targeting groups or imaging probes.4,5 Also, more than
one guest, e.g., two diﬀerent drugs or a drug and an imaging
agent, can be encapsulated, which might allow for the real-time
monitoring of the distribution of a drug in the body.
Furthermore, the particle size is an important factor for the
drug transport, because renal excretion through the kidneys as
well as the capture by the immune system has to be prevented
in order to increase blood circulation times and achieve a
therapeutic eﬀect. The threshold of renal clearance is about
45 kDa (4–6 nm in hydrodynamic diameter)6,7 and the immune
system especially acts on highly charged and large particles
(more than several hundreds of nanometres). Therefore, the
ideal size of a nanocarrier for drug delivery purposes is between
10 and 200 nm and it should not bear a charge, i.e., a positive
charge.8,9 However, one has to keep in mind, that the carrier
system at a certain point should also be excreted from the body.
In this context, it is desirable to develop big nanocarrier
systems that can degrade after their duty is done. It is self-
evident that the resulting fragments, like the carrier itself, have
to be biocompatible and nontoxic.
Further advantages of macromolecular nanocarriers are
their ability to enhance the uptake of drugs or imaging agents
by passive and active targeting.10,11 Passive targeting is possible
through the so-called enhanced permeation and retention
(EPR) eﬀect:12 tumour and inflamed tissue often exhibits a
more porous and disruptive endothelial cell layer due to their
rapidly forming vasculature. This allows the entry of large
molecules, which accumulate due to the less developed lym-
phatic drainage system. In contrast, small-molecular compounds
easily diﬀuse into diseased and healthy tissue, in which they
can cause severe side eﬀects. Active targeting can be achieved
by the attachment of targeting moieties to the surface of
the nanocarrier.
The properties of the outer functional groups also dictate
the pharmacokinetic behaviour and distribution profile in the
body. Additionally, the introduction of (bio)degradability is a
field of intense research.
Another example is catalysts, which can be soluble in their
non-solvents when they are encapsulated in a carrier. This is
not only attractive for being able to use cheaper and more
environmentally benign solvents, but might also have an influ-
ence on their catalytic activity. Here, the high surface-to-volume
ratio as well as the high density of functional groups can have a
beneficial influence on the stabilization and activity of cata-
lysts. However, it is usually not desired to transport and release
a catalyst, but rather to bind and protect it. Ideally, the
application of nanocarriers in this field enables the recovery
and recycling of an often expensive catalyst. In some cases an
additional beneficial eﬀect was observed due to the high local
concentration of catalytic sites at the surface of a dendritic
polymer. This so-called dendritic eﬀect can result in higher
reaction rates as well as better selectivities as compared to
reactions with the corresponding monomeric catalysts.
An important advantage of using macromolecules as carriers
for catalysts is the facilitated separation of the polymer-stabilized/
bound catalysts from the reaction medium. Applicable methods
are, e.g., precipitation, membrane filtration, liquid–liquid extrac-
tion, centrifugation, and size exclusion chromatography. The
goal is the recycling of expensive catalysts as well as the easy
purification of the reaction products from catalyst residues,
which can be toxic metal residues. The leaching of catalyst
from these polymeric systems is a problem in these applica-
tions and needs further improvement.
The two major approaches for the formation of nanocarriers
from soluble macromolecules are (1) the self-assembly of amphi-
philic block copolymers to form micelles and (2) the synthesis
of a multifunctional core molecule that can be equipped with a
functional shell (Fig. 1). With the first approach, core–shell
structures are obtained, which exhibit a hydrophobic interior
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surrounded by a hydrophilic shell. This structure can easily
encapsulate hydrophobic guest in its interior driven by hydro-
phobic interactions. A related type of macromolecular self-
assembly is vesicles, in which the amphiphile forms a bilayered
structure with an aqueous core and a hydrophilic outer shell,
which is in contact with the surrounding water. These struc-
tures are able to transport hydrophilic guests in the aqueous
core as well as hydrophobic guest in the bilayer.
There are certain drawbacks associated with the use of
amphiphilic block copolymers for the construction of self-
assembled nanocarriers. First of all, they are very sensitive to
their surrounding, i.e., ionic strength, pH, and temperature of
the medium or the presence of enzymes.13,14 The second, and
most prominent disadvantage is the fact that once they are
diluted to a concentration below their critical micelle concen-
tration, micelles usually fall apart if they are not especially
stabilized, e.g., by cross-linking of the core and/or shell.
Dendritic polymers are divided into two major classes: perfect
dendrimers and hyperbranched polymers. Dendrimers are per-
fectly branched architectures with a degree of branching of 100%
and consequently exhibit a polydispersity index of 1, meaning that
they are monodisperse.16–18 Compared with nanocarriers based
on amphiphilic block copolymers that exhibit low membrane
fluidity, dendritic polymers show a superior stability and tough-
ness, lower permeability and good fluidity owing to less entangle-
ment among the polymer chains. A drawback is their tedious
multistep synthesis, which makes them rather expensive and
limits their availability. In contrast, randomly branched poly-
mers, so-called hyperbranched polymers, are obtained through
fast and cheap one-step polymerization reactions and exhibit
properties very similar to those of their perfect dendrimer analo-
gues. Therefore, hyperbranched polymers are a good alternative
for perfect dendrimers and their use as nanocarriers will be
outlined in more detail in the following.
Many types of hyperbranched polymers are available, e.g.,
polyesters, polyethers, polyamines and polyamides.19 In addition
to carriers solely consisting of the hyperbranched polymer, other
architectures are available, e.g., core–shell and core–multishell
polymers, linear–hyperbranched hybrid copolymers, and
hypergrafted polymers as well as core–shell structures with a
hyperbranched core surrounded by a hyperbranched shell
(Fig. 2).
There are two major ways to transport guest molecules: by
covalent binding to the carrier or by encapsulation. In both
cases, the guest molecule has to be released at the desired site
of action. For covalently bound guest molecules, which are
mostly used in drug delivery,20 this involves the cleavage of the
bond between the drug precursor and the carrier by an external
trigger, e.g., pH, redox potential, enzymatic cleavage, irradia-
tion, and temperature changes.21 Since the active drug is only
generated upon release, its precursor cannot do any harm
beforehand; however, this approach requires the development
of prodrugs as well as carriers that possess appropriate func-
tional groups for coupling, which complicates their synthesis
significantly. The alternative is the noncovalent encapsulation
of guest molecules by physical interactions. Theoretically, one
type of carrier can be used to transport a range of guest
molecules, which makes it a more modular approach. This
review will concentrate on the second approach and highlight
recent advances and developments achieved in the area of
noncovalent drug encapsulation.
The transport properties of dendritic systems are influenced
by three factors: (1) the core of the carrier, determining its
shape; (2) the internal structure, determining the dimension of
the internal domain and the interactions between guest molecules
and the host; and (3) the outer shell, determining the solubility
properties as well as the accessibility of the carriers’ interior,
thereby influencing the loading as well as release properties.22
Fig. 1 Schematic representation of amphiphilic hyperbranched polymers
forming micelles, membrane, and vesicle. Modified from ref. 15. With
permission of WILEY.
Fig. 2 Diﬀerent architectures of nanocarriers and nanocarrier building
blocks containing hyperbranched polymers. The colours indicate a polarity
gradient (blue hydrophilic, green hydrophobic).
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The incorporation of guest molecules into macromolecular
nanocarriers is based on noncovalent interactions, for example,
hydrophobic interactions, hydrogen bonding, p–p interactions
between the guest molecule and the nonpolar core, and electro-
static interactions.
The interior of the nanocarrier determines the amount and
size as well as the polarity of the guest molecules that can be
incorporated. However, the interior does not necessarily have to
be hydrophobic in order to encapsulate hydrophobic guests. In
case of water-soluble carriers the encapsulation mechanism
can also be based on hydrotropic interactions between guest
and host.23 Even more important is the influence of the shell
properties (size, ionization, density) on the encapsulation.
Nowadays, the adjustment of the shell to improve the loading
capacity as well as release behaviour has become an important
area of research. Also, the shell controls the protein corona that
will form, when exposed to biological fluids.
Nanocarriers based on dendritic polymers exhibit an excel-
lent (in vivo) stability; however, for many applications the
release of encapsulated guests is desirable. This is especially
interesting for drug delivery and can be achieved by diﬀerent
mechanisms, e.g., by diﬀusion through the polymer matrix,
swelling followed by diﬀusion, or in response to the environ-
ment. Such a response can be based on a specific stimulus of
chemical, biochemical, or physical origin that leads to a change
of the structural composition or conformation of the nano-
carrier. Possible triggers are pH, temperature, salt concentration,
redox potential, light, ultrasound, or the presence of enzymes.9
The changes can be decomposition, ionization, isomerisation, or
depolymerisation.
In the following chapter, recent results obtained in the
synthesis, modification, and application of water soluble nano-
carrier systems based on hyperbranched polymers will be
presented. Special attention is given to the diﬀerent ways of
functionalisation and modification that have been investigated
in order to achieve the desired nanocarrier properties. The follow-
ing chapter is divided according to diﬀerent types of hyper-
branched polymers and the special features of each polymer
will be introduced. We will concentrate on nanocarriers con-
structed from soluble macromolecules, thereby excluding hybrid
nanocarriers with solid cores (e.g., with a metal, metal oxide,
mesoporous, and magnetic core). Also, we focus on water-
soluble systems. However, the reader will realize that it is easily
possible to solubilise a wide range of nanoparticles simply by
attaching an appropriate functional shell.
Nanocarriers based on diﬀerent
hyperbranched polymer types
Hyperbranched polyethers
Hyperbranched polyglycerol. Hyperbranched polyglycerols
(hPGs) are synthesized by a simple ring-opening multi-branching
(ROMB) polymerization of glycidol24–26 and exhibit unique proper-
ties related to their size in the nanometre range. These properties
can be further tuned by functionalisation. Additionally, hPGs are
highly biocompatible, water-soluble, and show a low viscosity,27–29
which prompt their use as nanocarrier systems.
Because they are not perfectly branched, hPGs possess two
types of hydroxy functionalities: linear monohydroxy and term-
inal dihydroxy units with the linear ones deriving from the
imperfect branching. Statistically, the linear hydroxy groups are
closer to the core, whereas the terminal ones are located at the
periphery of the molecule.30 Therefore, the hydrophobicity and/
or hydrophilicity of hPGs can be tailored by post-synthetic
chemical modification of the specific linear or terminal hydroxy
groups. Such a fine-tuning can be achieved by applying standard
hydroxy group chemistry, thereby transforming them, e.g., to
azides, alkynes, and amines, which oﬀers promising options for
the preparation of amphiphilic core–shell structures.30,31
Our group reported a series of nanocarriers based on hyper-
branched polyglycerol, exhibiting a core–(multi)shell architecture
(Fig. 3). In solution (e.g., water and organic solvents), these
Fig. 3 (a) Diﬀerent modification of hyperbranched polyglycerol as nano-
carrier systems for drugs/dye delivery applications. (b) Structure of core–
multishell (PG-C18-PEG350) based on SANS data and cryo TEM. Modified
from ref. 35, 37, 39–42 and 44 with permission from The American
Chemical Society, Elsevier B. V. and The Royal Society of Chemistry.
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amphiphilic core–shell nanocarriers either exist as unimolecular
micelles or they form multimolecular aggregates. These system
are able to increase the solubilisation of drugs and dyes such as
nimodipine, pyrene, and Nile red in water.32–38 However, recent
findings indicate that the core–multishell (PG-C18-PEG350)
nanocarrier forms a multidomain structure that facilitates
aggregation (see below).
Because many drugs are hydrophobic compounds that can-
not be easily administered to the patient, nanocarriers, which
are able to encapsulate and transport hydrophobic molecules,
are of great interest. When using unimolecular hPG nano-
carriers, the introduction of hydrophobic units into the poly-
mer structure is often the only means to enable the transport of
hydrophobic compounds. Two major approaches are available,
which either introduce the hydrophobicity directly in the core
or on the periphery of the hPG core. Kurniasih et al. reported
on a series of core–shell architectures based on hPG, in which
they made use of the different types of hydroxy groups (linear
and branched) of hPG.37 The linear groups in the core were
selectively functionalized with aromatic and perfluorinated
groups, whereas the peripheral groups were regioselectively
PEGylated to improve the solubility of the nanocarrier system.
The resulting nanocarrier systems encapsulated Nile red and
pyrene by different mechanisms and were also able to release
the guest molecules. Pyrene was found to be solubilised in the
core of the unimolecular carrier and its release was achieved
in the presence of an enzyme, which selectively cleaved the
biphenyl esters in the core of the polymer. In contrast, Nile red
was solubilised in polymer aggregates, which broke down to
single molecules upon dilution, leading to the release of the
guest; a behaviour that is similar to that of polymeric micelles.
The different encapsulation mechanisms and controlled
release properties make these nanocarrier systems promising
candidates for the simultaneous delivery of two hydrophobic
drugs, which is a current need in combination therapy, e.g., for
cancer treatment.37
The second approach of introducing hydrophobicity was
inspired by the lipid bilayer of liposomes. These artificial
vesicles have a polar core (water) surrounded by a lipid bilayer.
In analogy, Haag and co-workers developed core–multishell
architectures with polarity gradient from the core to the shell
(Fig. 3b).35,43 These so-called core–multishell nanoparticles
exhibit a polar interior (hPG), a hydrophobic inner shell, and
a hydrophilic outer shell. They are able to solubilise both
hydrophobic and hydrophilic guest molecules such as Nile
red and Congo red. A careful investigation of the loading
behaviour in dependence on the guest and the concentration
revealed that the dye loading triggers an aggregation of the
core–multishell nanocarriers giving aggregates with radii of
100–120 nm. Such results underline the necessity of system-
atically studying the influence of various facts that might
influence the size of nanocarrier/guest assemblies. Ballauff
et al. recently analyzed the structure of these core–multishell
nanocarriers using small-angle neutron scattering (SANS) with
contrast variation.44 In the nonpolar solvent toluene, the nano-
carriers form rather compact structures. A fractal structure with
a correspondingly rough surface is found here as well, which
is explained by the backfolding of the hydrophilic mPEG
chains in the nonpolar environment. In water the nanocarriers
associate to form well-defined nanoparticle clusters with an
ellipsoidal shape.
This finding is explained by a local demixing of the hydro-
phobic parts of the polymer multidomain nanoparticles. There-
fore, these particles carry hydrophobic patches on their surface
which lead to aggregation.
Burt and co-workers also synthesized core–shell structures,
whose hPG core was functionalized with C8/10 chains, whereas the
periphery was derivatized withmethoxy poly(ethylene glycol).45,46 In
one study, these polymers were further functionalized with
carboxylate groups to bind and deliver the anticancer drug
cisplatin.45 A higher amount of carboxylate groups was shown
to result in a higher binding efficiency for cisplatin. At mildly
acidic pH, the release of cisplatin from the nanocarriers with a
high amount of carboxylate groups was significantly slower
than from those with a lower density of carboxylates. This offers
a convenient handle to tune the release kinetics. The carboxylate
functionalized polymers showed good biocompatibility and the
drug-loaded analogues were shown to successfully inhibit the
proliferation of model bladder cancer cells. In another
approach, the same type of polymers were functionalized with
amine groups at their periphery.46 The resulting nano-
carriers were loaded with docetaxel and also tested in a
mouse model of bladder cancer. Upon treatment, no apparent
signs of local or systemic toxicity were observed and the
nanocarrier-drug formulation showed a significantly higher
effectivity in reducing the tumour growth.
Another way of introducing functionality into a hyperbranched
carrier was demonstrated by Nowag et al., who presented the
functionalisation of hPG derivatives with ethylethylene diamine
moieties (Fig. 6).47,48 These groups were introduced to achieve
Cu-binding by the formation of square planar bidentate com-
plexes. These interactions are reversible and enabled the
pH-dependent release of Cu. These eﬃcient copper nanocarriers
were also able to cross an artificial blood brain barrier. Copper
levels in the brain supposedly have an influence on Alzheimer’s
disease and the developed nanocarriers were tested as a treatment
option. The carriers itself were shown to have a low toxicity, which
makes them good candidates for balancing Cu levels in neurode-
generative diseases (Fig. 4).
Wyszogrodzka et al. introduced a convergent approach to
biocompatible polyglycerol ‘‘click’’ dendrons for the synthesis
Fig. 4 Nanocarriers based on hyperbranched polyglycerols for the trans-
port and release of copper ions. Modified from ref. 47 with permission
from The Royal Society of Chemistry.
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of modular core–shell architectures. By applying the Williamson
ether synthesis followed by an ozonolysis/reduction procedure,
glycerol based dendrons were prepared up to the fourth
generation. These structures could be used to observe the
structure-transport relation.49 Similarly, a rather robust modular
approach for the construction of nanocarrier systems was
developed by Zimmerman and co-workers, who generated
water-soluble alkyne-functionalized hPGs (Fig. 5).50 They were
used for the preparation of potential biological imaging agents.
Investigated examples include monofunctionalised fluorescein
or biotin hPGs, gold nanoparticles, and unimolecular acid-
labile micelles that can be used for the incorporation of
nonpolar guest molecules. In this work, the alkyne functional
groups served as the universal handle for the modular synth-
esis, because they could be reacted with any molecule bearing
an azide group in a simple click reaction.
To introduce bigger cavities into the hPG-based unimolecu-
lar carriers while at the same time generating a more dense
shell, Burakowska et al. used hPG as the core and the outer
shell, both of which were separated by a long aliphatic
hydrophobic inner shell.39 These globular nanocarriers possess
the ability to encapsulate polar guest molecules such as Rose
bengal and Congo red, but also unpolar compounds such as
nimodipine, Nile red, and pyrene. It was shown that nonpolar
guest molecules are transported by the unimolecular mecha-
nism, whereas polar guest molecules induced the formation of
aggregates with diameters of about 70 nm. The transport
capacity was much higher with the aggregates (10 guest molecules
per nanocarrier) than compared to the unimolecular system
(1.5 guest molecules per nanocarrier).
The transport and delivery of DNA and RNA for therapeutic
purposes is a particularly challenging area of research. Here
diﬀerent criteria are necessary to achieve a good transport and
at the same time guarantee a high biocompatibility. On the one
hand, a suﬃciently high density of cationic groups is required
to bind the RNA or DNA guest molecules, but on the other hand
it is exactly this high density of positive charge that induces a
high toxicity of the carrier after the release of the guest. There-
fore, it is desirable to be able to precisely control the amount of
charge on the nanocarrier. Fischer et al. reported the synthesis
of responsive core–shell architectures with a star-like oligo-
amine shell,51 which were used for siRNA complexation. The
variation of shell length and nitrogen content was investigated.
In contrast to polyethylenimine (PEI) and other known poly-
amines used for gene delivery, these novel compounds carry
charges only on their surface or shell, whereas the core consists
of a highly biocompatible noncharged aliphatic polyether. This
overall reduced amount of charge significantly reduced the
toxicity of the carriers. The in vitro gene silencing properties
were found to be similar to those of positive control samples
with a comparable low toxicity. Because of their high bio-
compatibility, these nanocarrier systems are potential candi-
dates for in vivo applications.
Another important aspect about the use of nanocarriers is the
controlled release of the guest molecules under certain external
stimuli or at a certain location. The introduction of functional
groups that can be cleaved upon the influence of a specific trigger,
is a promising strategy to achieve such a controlled release. Haag
and co-workers synthesized photolabile cross-linked hPG nano-
carriers (Fig. 6).40,41 These nanocarriers were used to selectively
and eﬃciently bind DNA and ionic compounds. In case of the
ionic guestmolecules it was found that the stability of the resulting
host–guest complex depends on the counterion of the guest
molecule, but can also be tuned by modification of the different
polymer building blocks, in particular the outer shell. The photo-
triggered degradation of the nanocarriers was used to release the
encapsulated guest molecules.40 In case of the DNA-binding
nanocarriers, the binding efficiency depended on the length and
density of the conjugated amines. Irradiation of the complexes led
to photolytic cleavage and release of the guests.41 These examples
show that the use of photolabile nanocarriers could be of parti-
cular relevance for biomedical applications, in which the selective
binding of guest molecules as well as their controlled triggered
release at a certain site is of crucial importance.
B.-S. Kim, Y. Shibasaki, and co-workers developed a light-
responsive micellar system using spiropyran (SP), a well-known
Fig. 5 Clickable nanocarrier system based on hPGs. (A) Hyperbranched
polymerization to form hPG, (B) click chemistry of hPG and (C) synthesis of
hPG coated gold nanoparticles. Modified from ref. 50 with permission
from The Royal Society of Chemistry.
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photochromic molecule, as the covalently bound core molecule
of hPGs (SP-hPG).52 In aqueous medium, these systems self-
assembled to polymeric micelles. However, upon exposure to
UV irradiation, the initially hydrophobic SP isomerised to form
the hydrophilic zwitterionic merocyanine, leading to the dis-
assembly of the micellar structures. This structural change of the
micelles was reversible upon exposure to visible light irradiation.
The prospective of the SP-hPG micelle for using it as a smart
drug delivery system was investigated using pyrene as a model
hydrophobic guest. The study demonstrated the successful
loading of the nanocarrier with pyrene and its release upon
external UV irradiation. The in vitro cytotoxicity tests with the
SP-hPG polymers showed excellent biocompatibility and no
toxicity of the SP-hPG micelles.
The same group also reported a one-pot synthesis of a hyper-
branched copolymer based on polyglycerol with poly(ethoxyethyl
glycidyl ether) (PEEGE) side chains, denoted PEEGE-b-(hPG-
co-PEEGE).53 The micelle formation as well as the ability to
encapsulate a guest molecule (pyrene) were investigated. Upon
a decrease of the pH, the hydrophobic PEEGE moieties were
deprotected to yield hydrophilic polyglycerol, leading to the
disassembly of the micelles and the release of the guest
molecules (Fig. 7). Cytotoxicity tests showed a high biocompat-
ibility, which makes these nanocarriers promising potential
drug delivery agents.
I. Kim et al. reported multibranched pentablock copolymers
with an inner PEG block, with hyperbranched polyglycerol
attached on both ends, followed by poly(L-lactide) [poly-
(L-lactide)-b-hPG-b-poly(ethylene glycol)-b-hPG-b-poly(L-lactide)].54
The multibranched pentablock copolymers exhibited a good
biocompatibility, rendering them suitable biomaterials for various
applications in biological medicine areas. The self-assembly of
the pentablock copolymers into spherical micelles was well
controllable and micelles with average diameters in the range
of 60–140 nm were obtained and demonstrated to be easily
loaded with drug. The anticancer drug doxorubicin was encap-
sulated into the copolymer system, and its controlled release
was achieved under various pH conditions.
For drug delivery applications, the targeted transport is also
a desirable feature of nanocarriers. A targeting ability can be
introduced by functionalisation with a targeting moiety. H. Kong
and co-workers synthesized bioactive hPGs for the association
with stem cells to fit them with the capability of targeting their
site of action such as inflamed endothelium.55 The overall
process would be analogous to the mobilization of leukocytes
to the injured endothelium.
Since the size of a nanocarrier in drug delivery determines
where it ends up in the body, how long it stays in the blood
stream, and how fast it is cleared from the body, it is highly
attractive to develop synthetic procedures that give access to
particles from the same type of material in a wide range of
diﬀerent sizes. Sisson et al. reported high-molecular-weight
hPG analogues, constructed by the cross-linking of existing
hPG macromonomers in miniemulsion.56,57 A nanoreactor
template was used to control the size of the resulting nanogels,
whereas the cross-linking was achieved by a ‘‘click’’ type
Fig. 6 Photoresponsive hyperbranched polyglycerols. (A) Photodegradable
hPG amine for reversible DNA complexation and (B) structure of cyclized
photoresponsive nanocarrier encapsulation of guest molecules (rose bengal)
and release of rose bengal sodium salt from polymer by UV irradiation at
l = 350 nm (upper), and the scheme of DNA–polymer complex formation
and release (lower). Modified from ref. 40 and 41 with permission from
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Fig. 7 The disassembly of the pyrene-loaded polymeric micelle under
acidic conditions. Reprinted with permission from ref. 53; Copyright 2013
American Chemical Society.




















































































4152 | Chem. Soc. Rev., 2015, 44, 4145--4164 This journal is©The Royal Society of Chemistry 2015
Huisgen alkyne/azide cycloaddition reaction. Nanogels in the
size range of 20–90 nm were obtained. These systems were used
to either covalently link or physically encapsulate dye or drug
molecules. The physical encapsulation was performed in dis-
persion before the cross-linking polymerization.
Steinhilber et al. improved this process by introducing
inverse nanoprecipitation approach, leading to hydrogel nano-
carriers in the size range of 100–1000 nm (Fig. 8).58 Biodegrad-
ability was achieved by introducing benzacetal groups as
pH-cleavable linkers. It was shown that at mildly acidic condi-
tions (pH 5), e.g., as in inflamed and tumour tissue, the acetal
groups are readily cleaved, resulting in the rapid degradation of
the hydrogel network. Under neutral conditions, however, they
remained stable. These scaffolds were used to encapsulate the
therapeutically relevant enzyme asparaginase with an efficacy
of 100%. After release, the structure and function of the enzyme
were maintained and it showed full activity. The goal of a
follow-up project was to avoid the use of metal ions in the
synthesis of these hydrogels, because they could promote the
formation of free radicals and damage sensitive biomolecules
and living cells. This was achieved by using droplet-based
microfluidics in combination with the bioorthogonal strain-
promoted azide–alkyne cycloaddition.59 Again, benzacetal linkers
were used to introduce degradability under mildly acidic con-
ditions. To achieve a homogeneous and efficient encapsulation
of cells, these had to be incorporated upon hydrogel formation.
The pH-triggered release of the living cells was shown and it
was found that the encapsulation as well as the release had no
influence on the cell viability.
Recently, hyperbranched nanogels for enzyme encapsula-
tion have been reported by C. Wu et al.60 The oxidative cross-
linking of hyperbranched polyglycerol (hPG) functionalized
with phenol groups hydrogels are successfully catalyzed by
horseradish peroxidase. The hydrogel properties can be adjusted
by tuning the crosslinking. They are cytocompatible and show
potential for encapsulating living cells for regenerative therapy.
The gel formation can be triggered by glucose and well con-
trolled under various environment conditions.
When nanocarriers are used for catalytic applications, the
requirements are a little bit diﬀerent, because the catalyst
should be encapsulated and stay in the nanocarrier. At the
same time, substrates that should be converted by the catalyst
have to be able to reach the catalytic site, whereas the products
have to be released by the carrier. Keilitz et al. employed
hPG-based nanocarrier systems for the synthesis and stabilization
of metal nanoparticles, e.g., gold, palladium, and platinum.61–63
Again, core–(multi)shell nanocarriers with a hydrophilic hPG core,
a hydrophilic outer shell, and in some cases a hydrophobic inner
shell were used. The platinum and palladium nanoparticles
supported by these polymeric nanocarriers were shown to be
active catalysts for CQC double bond hydrogenations.63 The size
and stability of the metal nanoparticles depended on the metal to
polymer ratio used during their synthesis. A lower metal loading
gave smaller particles with higher activity. Additionally, it was
shown that the surface of the platinum particles is not blocked by
the polymeric stabilizer and it was still possible to functionalize
the nanoparticles with chirality-inducing cinchonidine for asym-
metric hydrogenation reactions.61
Hyperbranched poly(1,3-diether). A new family of hyper-
branched polymeric ionic liquids (hyperILs) with an onion-like
topology, containing a core of hyperbranched poly(1,3-diether),
a polar inner imidazolium cation shell, and a nonpolar outer
alkyl shell have been developed by R. Mu¨lhaupt and co-workers
(Fig. 9).64 Due to the unique properties of hyperILs such as high
thermal stability up to 300 1C and extraordinary roughness,
these hyperILs can be used in reaction media, dispersion
processes, and even in the harsh environment encountered in
polymer melt compounding. Their polarity can be tailored as a
function of the n-alkyl chain length and the type of counter-
anion. The hyperILs can be used as nanoreactors and hosts for
a variety of functional materials.
Hyperbranched poly(3-ethyl-3-(hydroxymethyl)oxetane) (HBPO).
HBPO was used as a core molecule for the development of novel
biomimetic hyperbranched copolymers by polymerization of
zwitterionic monomers on the HBPO surface functional groups
by X. Wang et al.65 These hyperbranched copolymers formed
micelles and showed low toxicity, favourable protein resistant
Fig. 8 (I) Schematic representation of the nanoprecipitation process.
(A) Injection of an aqueous solution of alkyne-functionalized polyglycerol
macromonomers (red spheres), azide functionalized polyglycerol macro-
monomers (blue spheres), and the proteins asparaginase, IgG, lysozyme,
and BSA (3D structure of a-helixes and b-turns). (B) Particle templation by
diﬀusion of aqueous phase (blue arrow) into acetone phase (violet).
(C) Particle gelation by azide alkyne [2+3] cycloaddition. (II) Representation
of the degradation-triggered release of a therapeutically relevant enzyme
and its catalytic conversion of asparagine to aspartic acid under ammonia
generation. Reprinted with permission from ref. 55; Copyright 2013
Elsevier B. V.
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properties, and were very stable in 100% fetal bovine serum.
Folic acid and rhodamine B were conjugated to the surface of
the micelles to enable targeted drug delivery as well as fluores-
cence activity, respectively.
Hyperbranched polyesters
Drug carrier systems that are not degradable may lead to an
accumulation in diﬀerent organs, causing toxic eﬀects or inflam-
mation. Due to this reason, the (bio)degradability of polymeric as
well as unimolecular micelles is a desirable property and a crucial
parameter for drug delivery applications. Hyperbranched poly-
esters are an example of biodegradable drug carrier systems.
Additional advantages are their low toxicity as well as their
nonionic and nonimmunogenic properties.
A. M. Nystro¨m et al. reported nanocarrier systems based on
hydrophobic Boltorn hyperbranched polyester cores (H30 and
H40) with hydrophilic poly(ethylene glycol) shells (PEG5k and
PEG10k).66,67 Boltorn is a hyperbranched aliphatic polyester
based on 2,2-bis(methylol) propionic acid (bis-MPA) as the
monomer unit. Toxicological tests did not indicate toxicity of
the resulting nanostructures. Doxorubicin (DOX) was success-
fully encapsulated in these hyperbranched carriers and encap-
sulation eﬃciencies of more than 30% were achieved. The
carriers with lower generation Boltorn and shorter PEG chains
exhibited a higher capacity for doxorubicin encapsulation. The
sustained release of doxorubicin over a prolonged time was
achieved and the drug exhibited a higher cytotoxicity compared
to free doxorubicin. Additionally, it was shown that the DOX-
loaded nanocarriers were internalized into cancer cells.
Similar amphiphilic hyperbranched copolymers with the abil-
ity to target bone were synthesized by X. Zhu and co-workers.
The hydrophobic hyperbranched polyester core was equipped
with a hydrophilic mPEG shell and alendronate (ALE) targeting
moieties.68 These amphiphilic polymers were tested as carriers
for bone-targeted drug delivery (Fig. 10). In aqueous solution,
H40-star-PEG/ALE was found to form micelles, which was
confirmed by transmission electron microscopy (TEM) and
dynamic light scattering (DLS) measurements. Testing of the
H40-star-PEG/ALE micelles with regard to cytotoxicity and hemo-
lysis showed a high biocompatibility of the nanocarriers.
Doxorubicin was encapsulated into the H40-star-PEG/ALE
micelles as a model anticancer drug. The eﬃcient uptake of the
resulting DOX-loaded micelles into cells was shown and a high
anticancer activity against HN-6 human head and neck carci-
noma cells was found. Since alendronate strongly binds to
hydroxyapatite (HA), which was confirmed in a HA binding
assay, these nanocarriers can be used to target bone structures
for the treatment of skeletal metastases.
Further biodegradability was introduced by D. Yan et al. by
adding labile linkages between core and shell. They synthesized
amphiphilic multiarm copolymers with a Boltorn core and hydro-
philic polyphosphate arms, which were connected through
disulfide linkages that can be cleaved in the presence of reducing
agents such as glutathione (GSH).69 The Boltorn H40-star-poly-
(L-lactide)-disulfide-poly(2-ethoxy-2-oxo-1,3,2-dioxaphos-pholane)
(H40-star-PLA-SS-PEP) were able to self-assemble in aqueous
solution, thereby forming micelles with an average diameter of
70 nm. An in vitro evaluation showed that upon exposure to a
reductive environment, the hydrophilic shell of the micelles
could be detached, resulting in a fast release of the encapsu-
lated drug (Fig. 11). An investigation of the intracellular drug
delivery against a HELA human cervical carcinoma cell line
showed, that the release was faster in HELA cells pretreated
with glutathione monoester than in non-pretreated cells. This
resulted in a higher cellular proliferation inhibition in glutathione-
pretreated cells compared to non-pretreated cells as it was
shown with a cytotoxicity assay. The introduction of bio-
degradability together with responsiveness against a reductive
environment is a promising approach to increase the eﬃciency
of hydrophobic drugs.
Fig. 9 Routes to nanostructured hyperILs with onion-like topology and
facile polarity design. Ts = p-toluenesulfonyl (tosyl). Reprinted from ref. 64,
Copyright 2013, with permission from WILEY-VCH.
Fig. 10 Synthesis of H40-star-PEG/ALE micelles and their application for
bone-targeted drug delivery. Reprinted with permission from ref. 68;
Copyright 2013 American Chemical Society.
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Hydrogels with attractive drug release characteristics were
prepared by A. Khademhosseini et al., using hyperbranched
polyester macromers.70 These nanocarrier systems were used
for the encapsulation of the hydrophobic drug dexamethasone
within the hydrophobic cavities of the hydrogel and a sustained
release of the entrapped drug was reported. The properties of
the hydrogel could be tuned by changing the cross-linking density.
With regard to an application in cellular therapies (e.g. tissue
engineering) the cell adhesion, spreading, and proliferation
on the hydrogel surface was investigated and found to be
better on the highly cross-linked, and therefore mechanically
stiﬀ, hyperbranched polyester hydrogels compared their softer
analogues. These results might help in the development of
materials that can be tailored to specific functions in tissue
engineering applications.
Hyperbranched polyethylene
Hyperbranched polyethylene with globular shape in aqueous
solution andmolecular dimensions in the nanometre ranges have
received broad interest for applications including controlled
drug delivery and release, phase transfer, and as unimolecular
nanocarriers.
Nanocarriers based on hyperbranched polyethylene core
and polyethylene glycol shell have been synthesized by Z. Guan
and co-worker. Nile red has been used as guest molecules to
studied the transport capacity of the nanocarrier systems. In
the light-scattering, fluorescence and UV-VIS spectroscopic
studies with Nile red in aqueous solution, unimolecular micellar
properties of the nanocarrier systems were observed. These
molecular nanocarriers can be promising candidates for drug
delivery and controlled drug release.71,72
The first tandem coordination, ring-opening, hyperbranch-
ing polymerization of ethylene for the eﬃcient synthesis of a
unimolecular core–shell nanocarrier was presented by C. S.
Popeney et al.73 Their nanocarriers consisted of a dendritic
polyethylene (hPE) core with a grafted hPG shell. Due to the
high hydrophilicity of hPG, the nanocarrier was water-soluble.
It was shown that the core–shell copolymer transports the
hydrophobic guests pyrene and Nile red by a unimolecular
transport mechanism and achieves an efficient transport of the
hydrophobic dye Nile red into living cells under biologically
relevant high dilution conditions, which was not possible with
the amphiphile-derived micelle (Fig. 12). This work clearly
demonstrated the advantages of unimolecular transport
systems for the delivery of hydrophobic guests under highly
dilute conditions, because this cannot be achieved with self-
assembled micellar nanocarriers. Thus, these unimolecular core–
shell nanocarriers are promising candidates for the formula-
tion and delivery of poorly water-soluble active agents across
cellular membranes.
Zhang et al. also showed the encapsulation of coumarin 153 in
unimolecular micelles of amphiphilic core–shell polymers
obtained by coupling chain walking copolymerization and ATRP
(atom-transfer radical polymerisation).74 Oligo(ethyleneglycol)-
methacrylate (OEGMA) was used as the comonomer to provide
both water solubility and thermosensitivity to the unimolecular
dendritic polyethylene amphiphiles. The temperature-sensitive
phase transition behaviour of these core–shell amphiphiles was
investigated by Rayleigh scattering. With increasing hydrophilicity
of the polymers, the lower critical solution temperature (LCST)
of the polymer solution increases.
Hyperbranched polystyrene
Hyperbranched polystyrene-based nanocarriers were grafted
with poly(N-isopropylacrylamide) (PNIPAm) chains by S.-Q.
Chen (Fig. 13).75 In THF, these systems exist as star-like
polymers. Upon replacement of THF with water, the nano-
carriers remained stable as unimolecular carriers; however, the
water-insoluble polystyrene collapses, thereby enabling the
encapsulation of hydrophobic chemicals. Due to the PNIPAm
arms, which is a thermoresponsive polymer, these systems
exhibited thermally induced shrinkage with an LCST of around
29–32 1C. As a hydrophobic model compound, pyrene was
successfully encapsulated.
Fig. 11 The self-assembly of H40-star-PLA-SS-PEP with doxorubicin.
Reprinted with permission from ref. 69; Copyright 2011 American
Chemical Society.
Fig. 12 Image of tumour cells showing the fluorescence of Nile red (red)
and DAPI nuclear stain (blue) for cells incubated with hPE–hPG uni-
molecular nanocarriers compared to cells treated with the amphiphile-
derived micellar nanocarriers at the same concentration. Reprinted with
permission from ref. 73; Copyright 2012 American Chemical Society.
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H. Nagashima et al. reported the synthesis of hyper-
branched polystyrenes (hPS) with tunable hydrophobicity/
hydrophilicity.76 This was achieved by introducing Cl groups on
the surface of the hyperbranched polymer, which were then
treated with amines to give hPS–NR3
+Cl. The hydrophilicity/
hydrophobicity of the nanocarrier can be tuned by choosing
a suitable R group. These systems were employed to synthe-
size and stabilize platinum nanoparticles, which were used
in a biphasic hydrogenation of stilbene and successfully
recycled (Fig. 14).
Hyperbranched poly(urea-urethanes)
Biocompatible amphiphilic hyperbranched poly(urea-urethane)s
were prepared by T. Loontjens et al. in a three-step one-pot
procedure.77 Thereby, the monomer generation, the polymer-
ization, and the functionalisation with mPEG occurs in one
reaction vessel. Additionally, the product can be isolated by a
simple precipitation step, rendering the overall process very
attractive for large-scale syntheses. In water, these polymers
formed spherical micelles; the primary micelles had diameters
of 12–28 nm, whereas at higher concentration aggregates with a
size of about 160 nmwere formed. Thesemicelles showed an lower
critical solution temperature (LCST) behaviour close to the human
body temperature and exhibited low cytotoxicity, which makes
them interesting candidates for drug delivery applications.
Hyperbranched polyethylenimine
Hyperbranched polyethylene imine (hPEI) can be synthesized
by ring-opening polymerization of aziridine. The presence of
the high amount of amino groups contributes to the unique
properties of these nanocarrier systems such as the ability to
simultaneously deliver ionic and apolar guests as well as to
release guest molecules upon an external trigger, e.g., pH and
solvent. However, the high cellular toxicity of hPEI limits its use
for biomedical applications.
B. Voit and co-workers studied the interactions of hyper-
branched hPEI decorated with various oligosaccharide shells
with water-soluble B vitamins (thiamine, riboflavin, cyano-
cobalamin, niacin, and pyridoxine), an estradiol derivative, and
pantoprazole (Fig. 15).78 It was found that the strength of the
interaction depends on the properties of the analyte molecules.
The strongest driving force for the formation of host–guest com-
plexes are ionic interactions. Additionally, it was shown that the
core–shell glyco architecture was a necessary prerequisite for
obtaining stable analyte–polymer complexes, because the com-
plexes with pure PEI were not stable under the shear forces
applied during ultrafiltration of the aqueous solution without
an adjusted pH. This allows the conclusion that robust non-
covalent interactions between the guest molecules and the
dendritic polyamine scaffold are required to be able to further
process these host–guest complexes.
Our group synthesized dendritic core–multishell (CMS)
architectures based on hPEI as a core, which were later inves-
tigated with hPG cores (see above). These nanocarriers enabled
the transport of hydrophobic (Nile red, pyrene, nimodipine)
and hydrophilic guest molecules (Congo red, Rose Bengal) in
both polar and nonpolar solvents (Fig. 16).43 Besides the hPEI
core, these nanocarrier systems contained linear amphiphilic
building blocks forming a hydrophobic inner shell followed by
a hydrophilic monomethyl poly(ethylene glycol) (mPEG) outer
shell. This external polar layer provides good solubility in water
as well as in organic solvents and a high degree of biocompat-
ibility. In addition, this nanocarrier system needs to self-
assemble to bigger aggregates in order to act as a carrier for
guest molecules. A unimolecular transport was not observed.
Because of their unique properties, these CMS nanoparticles
Fig. 13 Synthesis strategy for star-like amphiphilic copolymers with
lsc–hPS core and PNIPAm grafting chains. Reprinted with permission from
ref. 75; Copyright 2013 Wiley Periodicals, Inc.
Fig. 14 Hyperbranched polystyrene and the stabilization of a platinum
nanoparticle by hPS–N(C12H25)3
+Cl. Reproduced from ref. 76 with per-
mission from The Royal Society of Chemistry.
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already found various biomedical applications, e.g., for the
in vivo targeting of a F9 teratocarcinoma tumour and the
modulation of the copper level in eukaryotic cells79,80 as well as
for enhancing the skin penetration ability of rhodamine B and
Nile red.81 It was also shown that the CMS nanotransporters
can benefit from the enhanced permeation and retention effect
(EPR effect), leading to an accumulation of the nanocarrier–
drug complex in diseased tissue resulting in the more selective
delivery of their payload.80
H. Pu et al. also reported a unimolecular micelle that is able
to deliver polar (Rose bengal, methyl orange) as well as apolar
(pyrene) guest molecules. The macromolecular nanocapsules
were based on hyperbranched polyethylenimine (hPEI) with a
hybrid shell of poly(ethylene glycol) monomethyl ether (mPEG)
and polystyrene (PS).82 Depending on the ratio of mPEG and PS,
the nanocapsules are soluble in a wide range of solvents as well
as in water. Their structure depends on the chosen solvent.
In water, they exist as onion-like particles with three layers
(hPEI-PS-PEG), whereas in chloroform a hybrid shell particle
(hPEI-PEG/PS) is present. In all cases, these particles exist as
unimolecular micelles. Their ability to act as nanotransporters was
demonstrated in biphasic mixtures of water and chloroform, in
which the nanoparticles can transfer anionic water-soluble guest
molecules from the aqueous to the chloroform phase. In aqueous
solution, the nanocarriers can be used to capture ionic as well
as apolar compounds. It was also shown, that guest molecules
can be released upon an external stimulus, which could either
be a change in pH or a switch of the solvent.
A novel supramolecular complex based on hPEI was
reported by Y. Chen et al.83 The simple mixing of hPEI with a
solution of amphiphilic calix[4]arene (AC4), containing four
aliphatic chains and four hydroxy groups in chloroform yielded
a supramolecular complex, which formed through the noncova-
lent interaction of amino groups of hPEI with the phenol
groups of the calix[4]arene (Fig. 17). The cationic water-
soluble dye methyl blue and the anionic water-soluble dye
methyl orange were used as model guest molecules to test the
performance of hPEI-AC4 as a supramolecular nanocarrier. It
was found that the water-soluble methyl orange is incorporated
in the core of hPEI-AC4, whereas the cationic water-soluble
methyl blue is accommodated within the AC4 moieties on the
Fig. 15 PEI-OS architectures and analytes used in the study by B. Voit and
co-workers. Top: the investigated PEI-OS architectures are shown with
the three types of oligosaccharides, Mal, Lac, Mal-III, that act as shell
components and with two PEI cores, PEI-5k and PEI-25k. The various
substructures A, B, and C and the diﬀerences in their oligosaccharide shell
densities are also illustrated. Reprinted from ref. 78; Copyright 2014, with
permission from WILEY-VCH.
Fig. 16 (a) Dendritic core–multishell (CMS) architectures based on hPEI.
CryoTEM measurement (b)–(e) of CMS based hPEI with 1 mg mL1
polymer concentration in pure water. The size of the unimers was
determined to be about 5 nm. (b) Aggregate diameters for pure multishell
nanocarriers were determined to be in a range of 30–50 nm. (c) After
encapsulation of nimodipine the size changed to diameters of 20–30 nm.
(d) Encapsulation of b-carotene increased the size of aggregates to
110–130 nm. (e) Enlargement from (d). (f) Model of a unimer (left) and
supramolecular aggregate (right). (g) Strong contrast was observed after
6 hours of administration of indotricarbocyanine tetrasulfate (ITCC) dye
loaded CMS nanoparticles to F9 tetracarcinoma (tumor tissue) bearing
mice. (h) Contrast achieved with free dye after the same time period is not
very prominent Reprinted from ref. 43 and 80; Copyright 2007, with
permission from WILEY-VCH and Elsevier B. V.
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surface. The encapsulation capacity for methyl orange was pH
dependent and reached its highest value at weakly acidic
conditions. When the pH value was outside the range of about
4.5 to 9.5, reversible release of the guest was observed. The
overall amount of encapsulated methyl orange and methyl blue
could be successfully controlled by the ratio of the hydroxy
groups of AC4 to the amino groups of hPEI.
The attachment of biodegradable and biocompatible poly-
peptides onto a hyperbranched PEI resulted in water-soluble
amphiphilic star-block-copolypeptides as reported by D. Liu
et al.84 As the inner hydrophobic shell, polyphenylalanine or
polyleucine was used, whereas the outer polyglutamate shell
was negatively charged. The polymers formed well-defined supra-
molecular aggregates with very low critical aggregation constants
(cac). In contrast to conventional micelles derived from surfac-
tants or linear amphiphilic block copolymer, these systems are
very stable upon dilution. It was shown that various compounds
ranging from hydrophobic to hydrophilic guest molecules, can
be encapsulated simultaneously.
S.-C. Jiang, Y. Chen, and co-workers reported amphiphilic
hyperbranched copolymers based on a hPEI core equipped with
generation 1 and 2 dendrons with two and four aliphatic tails,
respectively.85 These systems were used for the encapsulation
of hydrophilic guests, including methyl orange, Congo red, and
Direct Blue 15, into the hydrophilic PEI core and showed higher
encapsulation capacities than analogues with a linear shell.
This study showed the potential of enhancing the encapsula-
tion capacity by introducing branching units into the outer
shell building blocks, thereby generating a much denser outer
shell with at the same time greater cavities. Additionally, the
presence of bigger cavities enables the encapsulation of bitter
guest molecules like Congo red and Direct Blue 15.
A multicompartment release system, which combines the
advantages of dendritic architectures and hydrogels was
described by N. Polykarpov et al.86 The developed hydrogel
contains dendritic glycopolymers as nanocontainers, which can
be employed as a delivery system for drug molecules. The glyco-
polymer is based on a hPEI core with a maltose shell (PEI-Mal)
and as a guest molecule adenosine triphosphate disodium salt
(ATP) was used. It was shown that the uptake and release of
ATP from the hyperbranched host depends on the dendritic
glycostructure and the pH and can be fine-tuned. It was possible
to achieve a selective release only of ATP or the simultaneous
release of ATP and the glycopolymer scaﬀold. This multicompart-
ment release system has the potential to enhance the desired
delivery features in complex biological environments with
changing pH values.
Hyperbranched poly(amido amine)s (hPAAs)
Hyperbranched poly(amido amine)s (hPAAs) containing diﬀer-
ent amounts of b-cyclodextrin (hPAA-CDs) were synthesized by
Chen et al. (Fig. 18).87 These nanocarriers were used as nonviral
gene delivery agents. It was shown that the cellular uptake of
the polymer–DNA complexes was very fast, resulting in trans-
fection efficiencies similar to those observed with pure hPAAs.
Fig. 17 Structure of supramolecular hPEI-AC4 nanocarriers with encapsu-
lated guests in isolated sites. Blue ellipses indicate methyl blue and dark
yellow ellipses indicate methyl orange. Reprinted with permission from
ref. 83; Copyright 2009 WILEY-VCH.
Fig. 18 Structure of hPAA-CD polymers. Reproduced from ref. 87; Copyright
2011, with permission from the American Chemical Society.
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The inner cavities of the nanocarriers were used to addi-
tionally encapsulate drugs. Therefore, these systems have
potential application, e.g., for the combination of gene therapy
and chemotherapy.
Y. Liu et al. presented redox-responsive gene delivery sys-
tems based on hyperbranched poly(amido amine)s (hPAAs).88
These nanocarrier systems contained a tertiary amino core
and diﬀerent terminal functional groups (amine, PEG, and
hydroxy). Although all polymers possessed the same redox-
responsive core, the diﬀerences of the structure of the terminal
functional groups resulted in a clear distinction in terms of
biophysical properties and transfection eﬃciency in vitro.
hPAAs terminated with 1-(2-aminoethyl)piperazine were found
to be the most eﬃcient for binding DNA. The core was found to
degrade rapidly upon cleavage of the disulfide bonds, resulting
in improved transfection eﬃciency. Overall, the study has
shown that the degradation of the gene delivery agent plays an
important role in achieving high transfection eﬃciencies and a
low cytotoxicity.
Heterogeneous catalysts based on water soluble metal nano-
particles have been developed and exhibited high eﬃciency and
environmental friendly properties.89 These metal nanoparticle
catalysts can be stable under shear forces and dilution. Poly-
(amido amine) (PAMAM) dendrimers have been shown to be
perfect nanoreactors and stabilizers for metal nanoparticles.90,91
In contrast to those perfectly branched but costly monodisperse
dendrimers, hyperbranched polymers analogous to PAMAM
dendrimers called HYPAM are easily accessible.92,93
J.-D. Marty et al. presented the synthesis and characteriza-
tion of platinum nanoparticles stabilized by hyperbranched
poly(amido amine) (HYPAM) (Fig. 19).94 These metal nano-
particles are suitable for use as reusable homogeneous hydro-
genation catalyst in water under mild conditions. S. Saliba et al.
used core–shell and core–multishell nanocarrier systems based
on hyperbranched poly(amido amine) polymers (HYPAM)
for the formation and stabilization of ZnO nanoparticles.95
These nanocarrier systems contained a hyperbranched poly-
(amido amine) core with a core–shell or a core–multishell
architecture based on PEG derivatives with poly(ethylene glycol)
as the outer shell. Due to this outer shell, the polymer–nano-
particle complexes could be easily redispersed in various solvents
with the ZnO nanoparticles showing stable photoluminescent
properties.
Branched thermotropic liquid crystals were successfully
obtained from ionic interactions between hyperbranched
poly(amido amine) (HYPAM) and sodium dodecylsulfate by
H. H. Nguyen et al.96 Polarized optical microscopy, diﬀerential
scanning calorimetry, and small-angle X-ray scattering showed
the complex formation of columnar rectangular and lamellar
thermotropic mesophases. The liquid crystalline phase was
then used for the in situ formation of gold nanoparticles. The
templating eﬀect of the liquid crystal mesophase resulted in the
formation of isotropic nanoparticles, the size of which was
dictated by the local organization of the mesophase and by the
molar mass of the hyperbranched complex. The presence of
NPs induced strong changes in the local organization of the LC
polymer, but nevertheless the obtained hybrid materials
remained liquid crystalline.
Hyperbranched polyphosphates
Polyphosphates are an important class of eminent biomaterials.
Due to their high biocompatibility, biodegradability, and
flexibility, they are widely used in biomedicine. A series of
phosphorus-containing dendrimers have been synthesized by
A.-M. Caminade and co-workers. They have shown that
phosphorus-containing dendrimers are useful for biological
purposes, in particular as transfection agents,97 anti-prion
(including in vivo)98 and anti-HIV agents,99 against Alzheimer
diseases,100 as imaging agents (including in vivo),101 for the
activation and multiplication of human monocytes and innate
immune natural killer (NK) cells,102 and as vehicle for ocular
drug delivery of carteolol.103
Since phosphate-based dendrimers are synthesized by mul-
tistep reactions, they are rather expensive nanocarriers, and
their hyperbranched analogues present a suitable alternative.
D. Yan and co-workers constructed full-polyphosphate nano-
carriers through the self-assembly of amphiphilic hyperbranched
multiarm copolymers.104 The hydrophilic core and the hydro-
phobic arms of the polymers (called HPHEEP-star-PPEPs) con-
sist of hyperbranched and linear polyphosphates, respectively.
In aqueous medium, these copolymers self-assemble to give
Fig. 19 Structure of hyperbranched poly(amido amine) (HYPAM) poly-
mers. Adapted from ref. 94 with permission from the American Chemical
Society and The Royal Society of Chemistry.
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nanocarriers with controlled sizes from 48 to 74 nm. Their size
can be controlled by adjusting the length of the hydrophobic arm.
It was shown that the nanocarriers are highly biocompatible and
are easily taken up by cells. The treatment of a breast cancer cell
line with the chlorambucil-loaded nanocarriers in vitro achieved a
higher proliferation inhibition than free chlorambucil.
To further improve the nanocarrier systems, the same group
introduced disulfide groups into the backbone of similar
amphiphilic copolyphosphates (HPHSEP-star-PEPx).
105 The
resulting nanosized micellar drug delivery systems exhibited
smart redox-responsive behavior (Fig. 20) as well as good
biocompatibility and biodegradability. In water, self-assembly
forms spherical micelles with tunable sizes from 70 to 100 nm.
Under reductive environment, the micelles are destroyed,
allowing a triggered drug release. This was demonstrated
by using doxorubicin-loaded HPHSEP-star-PEPx nanocarriers
against a HELA human cervical carcinoma cell line. It was
found that the doxorubicin-loaded nanocarriers showed a higher
cellular proliferation inhibition in a reductive environment
(glutathione monoester).
J. Ji and co-workers successfully prepared biocompatible
photo-responsive biocompatible micelles consisting of an amphi-
philic hyperbranched polyphosphate.106 The light-responsiveness
was achieved by attaching 2-diazo-1,2-naphthoquinone-5-sulfonyl
chloride (DNQ) groups. In aqueous solution, this polymer forms
micelles with average sizes around 180 nm. As a model drug,
coumarin 102 was encapsulated and shown to be released in a
controlled manner under UV irradiation at 365 nm.
The synthesis of biocompatible and biodegradable nanogels
with a branched structure through a miniemulsion process invol-
ving an ionic liquid was developed by J. Wang et al. (Fig. 21).107
These nanogels were shown to easily encapsulate doxorubicin and
the release could be triggered by an enzyme. The eﬃcient uptake
of these nanocarriers was shown for a human breast cancer cell
line. Additionally, surface functionalisation was demonstrated
by attaching a fluorescein dye and it was found that the
nanogels are able to prevent protein adsorption.
Other hyperbranched polymers
Hyperbranched polypeptides. Peptides fulfil unique recogni-
tion and communication functions, e.g., in the connective
tissues and the extracellular matrices of mammals. To under-
stand the structure–property relationship as a biomimetic
model and for biomedical applications, synthetic polypeptides
with tuneable dendritic topologies need to be developed.
Hyperbranched poly(e-benzyloxycarbonyl-L-lysine) (hPlys) with
alkyne peripheries was synthesized by C.-M. Dong et al. through
click polycondensation of AB2-type macromonomers.
108 Func-
tionalisation with poly(ethylene oxide) produced hPlys-b-PEO
block copolymers (Fig. 22), which self-assemble to spherical
micelles in aqueous solution. Compared to a linear analogue,
hPlys exhibited a significantly lower critical aggregation concen-
tration and a higher drug-loading capacity and efficiency for
doxorubicin. The drug release rate of the nanocarriers derived
from the hyperbranched polymer was lower and their burst-
release profile was improved.
Hyperbranched polysaccharides. Due to their diverse bio-
activity profiles, hyperbranched polysaccharides have potential
Fig. 20 Structure of the amphiphilic hyperbranched copolyphosphates
(upper part). Representation of the redox-responsive behavior of
HPHSEP-star-PEPx micelles for intracellular drug release triggered by
glutathione. Adapted with permission from ref. 105; Copyright 2011
American Chemical Society.
Fig. 21 The synthesis of nanogels based on polyphosphates. Repro-
duced with permission from ref. 107; Copyright 2012 The Royal Society
of Chemistry.
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applications in the fields of biochemistry and pharmacology.
T. Satoh et al. polymerized 1,6-anhydro-D-hexofuranoses with a
thermally induced cationic catalyst (Fig. 23).109 The resulting
hyperbranched polysaccharides were demonstrated to exhibit a
strong interaction with the lectin Concanavalin A (ConA), which
is a carbohydrate-binding protein. This demonstrated the cluster
eﬀect of the numerous nonreducing saccharide units on the
surface of the polymers. Their use as drug carriers, sensors for
lectin recognition, and as stationary phase for lectin chromato-
graphy was proposed.
Hyperbranched polyacrylates. Nucleic acid therapy for the
treatment of various diseases resulting from genetic disorders
faces the problem of low transfection eﬃciencies, which derive
from the polyanionic phosphate backbone and the general
nuclease instability. Therefore, nanocarriers are required to shield
and protect their cargo and one option is cationic polymers.
K. Matyjaszewski and co-workers reported the synthesis of
cationic hyperbranched polyacrylates based on poly(ethylene
glycol) (PEG) by atom transfer radical polymerization (ATRP;
Fig. 24).110 Polyplexes formed from these polymers and pDNA
or siRNA were shown to be highly eﬀective in nucleic acid
delivery. This study highlights the importance of developing
appropriate carriers for nucleic acid delivery.
Hyperbranched b-cyclodextrin. Hyperbranched poylyglycerol
grafted from b-cyclodextrin has been synthesis by D. Yan and
co-worker (Fig. 25).111,112 Using the noncovalent coupling
between a hydrophobic hyperbranched poly(3-ethyl-3-oxetane-
methanol) with an apex of an azobenzene (AZO) group and
a hydrophilic hyperbranched polyglycerol with an apex of a
b-cyclodextrin (CD) group through the specific AZO/CD host–
guest interaction, Janus hyperbranched polymers were con-
structed. Such an amphiphilic supramolecular polymer
resembles a tree together with its root very well in the archi-
tecture and can further self-assemble into unilamellar bilayer
vesicles with narrow size distribution, which disassemble
Fig. 22 Hyperbranched poly(e-benzyloxycarbonyl-L-lysine) (hPlys) and
the related hPlys-b-PEO block copolymer. Reproduced with permission
from ref. 108; Copyright 2013 American Chemical Society.
Fig. 23 Hyperbranched polysaccharides complexes with Concanavalin A.109
Copyright 2011, with permission from the American Chemical Society.
Fig. 24 Synthesis of star polymers with a cationic core (S–NH) for siRNA
or pDNA delivery by ATRP. Reproduced with permission from ref. 110;
Copyright 2013 American Chemical Society.
Fig. 25 Self-assembly and disassembly processes of the supramolecular
Janus hyperbranched polymer of HBPO-b-HPG. Reprinted with permis-
sion from ref. 112; Copyright 2013 American Chemical Society.
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reversibly under the irradiation of UV light due to the trans-to-
cis isomerisation of the AZO groups. The obtained vesicles
could advance aggregate into colloidal crystal-like close-packed
arrays under freeze-drying conditions. The computer simula-
tion of the self-assembly process and the vesicular structure by
a dissipative particle dynamics simulation as shown a consis-
tent result with the experimental result.
T. Satoh et al. introduced a hydrophilic nanocapsule based
on a hPEI core modified with b-cyclodextrin (CD) and a poly-
(ethylene oxide) (PEO) shell.113 These nanocarrier systems were
shown to eﬃciently encapsulate the hydrophobic guest molecule
pyrene and exhibited unique release properties: the release can be
chemically triggered on-demand and depends on the amount
of the chemical that is used as the stimulus. Additionally, the
carriers showed a high pH sensitivity. The chemoselective release
is attributed to a synergic eﬀect of the structural features of the
nanocapsule, which a single building block (cyclodextrin or the
covalent micelle) does not possess alone. It was reasoned that
the synergic eﬀect results from the entrapped pyrene, which is
partially exposed from the cyclodextrin moiety and therefore
sensitive to the environment.
Conclusions
The choice of the optimal hyperbranched nanocarrier certainly
depends on the desired application; however, some require-
ments apply in general. These are the controllable synthesis
(with regard to the reproducibility, size, dispersity, functional
groups), an easy functionalisation to adjust the properties, a
high loading capacity for the desired guest molecule, good
solubility in the required medium, high stability, reasonable
price. Also the actual architecture of the nanocarrier or aggre-
gates in water plays a major role. The diﬀerent types of nano-
carrier aggregates as well as the properties of nanocarriers are
yet poorly understood and need further investigation.
 For the most common application, i.e., drug delivery, the
most stringent requirements apply. These are, for example,
high biocompatibility of the nanocarrier as well as of all
possible degradation products, the degradability and/or elim-
ination of the nanocarrier after the delivery, high stability on
the shelf as well as under physiological conditions, targeting of
the diseased tissue.
 Further relevant parameters are increased blood circula-
tion times; controlled release mechanism, high uptake eﬃciency,
high loading capacity, low aggregation tendency or controllable
aggregation; triggered release; nontoxic, nonimmunogenic,
cheap production. The self-assembly behaviour of hyperbranched
polymers in the presence of the guest molecules, such as drugs,
dye, proteins, DNA/RNA as well as buﬀer systems/serum also
need more investigations to develop more eﬃcient nanocarrier
systems under physiological conditions.
 Nanocarrier systems also can be used as carriers for
catalysts, the major advantage being facilitated separation of the
polymer-stabilized/bound catalyst from the reaction medium. By
using nanocarrier systems, expensive catalysts (metals, enzymes)
can be recycled in a straight forward manner. The purifica-
tion of reaction products from catalyst residues can be
accommodated.
The future of hyperbranched nanocarriers is bright as they
will move more into applications with the ease of synthesis and
scale up being the major driving forces. The diﬀerent topolo-
gies, flexibilities and composition of nanocarrier system are
expected to extend the categories and functionalities of the here
presented functional hyperbranced polymers.
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